GGrantIndex
← Search

TARGETING ANDROGEN RECEPTOR IN BREAST CANCER: ENZALUTAMIDE AS A NOVEL BREAST CANCER THERAPEUTIC

$4,087,634FY2013Department of the ArmyDOD

The Regents Of The University Of Colorado

Investigators

View source on USAspending →
TARGETING ANDROGEN RECEPTOR IN BREAST CANCER: ENZALUTAMIDE AS A NOVEL BREAST CANCER THERAPEUTIC · GrantIndex